| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1081/PRG-120028292 |
| P698 | PubMed publication ID | 15369650 |
| P50 | author | Marinus Blankenstein | Q42683705 |
| John M G van Vugt | Q125193610 | ||
| P2093 | author name string | Cees B M Oudejans | |
| Inge J van Wijk | |||
| May Lee Tjoa | |||
| P2860 | cites work | Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia | Q22254337 |
| Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia | Q24310876 | ||
| Inflammatory markers and coronary heart disease | Q28193527 | ||
| The vascular endothelial growth factor family: signalling for vascular development. | Q33737967 | ||
| A regulatory role for neurokinin B in placental physiology and pre-eclampsia | Q33936241 | ||
| Fetal DNA in maternal plasma: emerging clinical applications | Q34351279 | ||
| The pathogenesis of pre-eclampsia | Q34383374 | ||
| Placental peptides as markers of gestational disease | Q34577159 | ||
| Pre-eclampsia: more than pregnancy-induced hypertension | Q34726951 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? | Q37366512 | ||
| Treatment of hypertension in pregnant women | Q41002739 | ||
| High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone | Q41171718 | ||
| Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia | Q41224815 | ||
| Selectins in normal pregnancy, pre-eclampsia and missed abortus | Q43602430 | ||
| Apoptosis in the placenta of pregnancies complicated with IUGR. | Q43619832 | ||
| Levels of dimethylarginines and cytokines in mild and severe preeclampsia | Q43662078 | ||
| Intrauterine growth restriction without pre-eclampsia and associated changes in serum inhibin A and activin A levels: a case report | Q43664284 | ||
| Multiple marker second trimester serum screening for pre-eclampsia | Q43692496 | ||
| Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia | Q43718487 | ||
| Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies | Q43868680 | ||
| A longitudinal study of biochemical variables in women at risk of preeclampsia | Q44062096 | ||
| Serum leptin levels and the severity of preeclampsia | Q44298373 | ||
| Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia | Q46354313 | ||
| Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy | Q46354783 | ||
| Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia | Q46373989 | ||
| Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin | Q47744568 | ||
| Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia | Q47751610 | ||
| Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. | Q54021736 | ||
| Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. | Q54230092 | ||
| THE LEVELS OF CIRCULATORY FETAL DNA IN MATERNAL PLASMA ARE ELEVATED PRIOR TO THE ONSET OF PREECLAMPSIA | Q56001888 | ||
| Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia | Q56794536 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia | Q57523598 | ||
| Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia | Q57671390 | ||
| Elevated C-reactive protein levels in overweight and obese adults | Q57830181 | ||
| Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia | Q58206283 | ||
| Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia | Q58377198 | ||
| P433 | issue | 2 | |
| P921 | main subject | maternal health | Q6786626 |
| pre-eclampsia | Q61335 | ||
| intrauterine growth restriction | Q1671598 | ||
| P304 | page(s) | 171-189 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Hypertension in Pregnancy | Q5958696 |
| P1476 | title | Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction | |
| P478 | volume | 23 |
| Q39469245 | Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease |
| Q46858348 | Alterations in syncytiotrophoblast cytokine expression following treatment with lipopolysaccharide |
| Q43203212 | Assessment of proteinuria in pregnancy |
| Q98611569 | Autophagy regulates trophoblast invasion by targeting NF-κB activity |
| Q37711864 | Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia |
| Q28241617 | Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound |
| Q34105037 | Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation |
| Q28218814 | Control of human trophoblast function |
| Q34168222 | Decidual-secreted factors alter invasive trophoblast membrane and secreted proteins implying a role for decidual cell regulation of placentation. |
| Q39798310 | Early biometric lag in the prediction of small for gestational age neonates and preeclampsia |
| Q83277637 | Expression of inhibin/activin subunits alpha (-alpha), beta A (-beta (A)) and beta B (-beta (B)) in placental tissue of normal and intrauterine growth restricted (IUGR) pregnancies |
| Q83947428 | Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies |
| Q37433832 | Genetic and environmental influences on birthweight in a sample of Korean twins |
| Q37763163 | Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management |
| Q38601408 | Ischemic placental syndrome--prediction and new disease monitoring. |
| Q37959563 | Linking preeclampsia and cardiovascular disease later in life |
| Q35620766 | Lipopolysaccharide induces cytokine production and decreases extravillous trophoblast invasion through a mitogen-activated protein kinase-mediated pathway: possible mechanisms of first trimester placental dysfunction |
| Q46524857 | Maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGF BP-3 and the hypertensive disorders of pregnancy |
| Q46807493 | Maternal serum inhibin-A for predicting preeclampsia |
| Q38088834 | Non-coding RNA and DNA as epigenetic biomarkers for pre-eclampsia |
| Q38080626 | Novel biomarkers for predicting intrauterine growth restriction: a systematic review and meta-analysis |
| Q58035975 | PROTEOMICS APPROACHES IN PRE-ECLAMPSIA RESEARCH |
| Q35058774 | Placental maturity, hypertensive disorders of pregnancy and birth weight. |
| Q81446389 | Pre-eclampsia |
| Q40895121 | Pre-pregnancy maternal plasma cytokine levels and risks of small-for-gestational-age at birth |
| Q46433977 | Prediction of maternal predisposition to preeclampsia |
| Q28391645 | Protective effect of nuclear factor E2-related factor 2 on inflammatory cytokine response to brominated diphenyl ether-47 in the HTR-8/SVneo human first trimester extravillous trophoblast cell line |
| Q34245904 | Proteomic biomarkers in second trimester amniotic fluid that identify women who are destined to develop preeclampsia |
| Q34662474 | Tetrabromobisphenol A activates inflammatory pathways in human first trimester extravillous trophoblasts in vitro |
| Q36831964 | Umbilical Vein and Maternal Serum Inhibin A, Activin A, and Follistatin Concentrations in IUGR due to Placental Dysfunction Pregnancies |
| Q37199643 | Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy |
Search more.